ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,966Medicare Part D Prescriptions Filled, Including Refills

Rank: 26 out of 122

$444K Total Retail Price of All Prescriptions

Rank: 24 out of 122

305 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Vermont
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 305 patients filled at least one prescription for a schedule two drug, compared to an average of 10%.

Schedule Three
Controlled Substances

13% of this provider’s 305 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 3,702 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Vermont
HYDROCODONE-ACETAMINOPHEN 326 85 S3 1 16
ZOLPIDEM TARTRATE 206 97 2 19
LISINOPRIL 204 118 3 2
OMEPRAZOLE 193 117 4 3
WARFARIN SODIUM 189 103 5 9
FUROSEMIDE 171 130 6 5
SIMVASTATIN 166 101 7 1
METOPROLOL TARTRATE 158 130 8 8
OXYCODONE-ACETAMINOPHEN 134 0 S2 9 41
LEVOFLOXACIN 125 53 10 80
LEVOTHYROXINE SODIUM 117 94 11 4
HYDROCHLOROTHIAZIDE 112 81 12 6
DOXYCYCLINE HYCLATE 110 70 13 135
TRAMADOL HCL 96 39 14 20
CITALOPRAM HBR 96 50 14 15
IBUPROFEN 90 24 16 68
METOPROLOL SUCCINATE 87 74 17 11
OXYCODONE HCL 87 0 S2 17 30
CYCLOBENZAPRINE HCL 84 26 R 19 93
CELEBREX 81 66 20 52
CLOPIDOGREL 72 50 21 45
AMLODIPINE BESYLATE 69 58 22 7
PANTOPRAZOLE SODIUM 67 39 23 23
FENTANYL 66 0 S2 24 47
CYMBALTA 65 0 25 62
DIGOXIN 64 54 26 74
ACETAMINOPHEN-CODEINE 62 30 S3 27 109
DILTIAZEM 24HR ER 59 39 28 108
NEXIUM 59 25 28 32
DEXILANT 59 12 28 122
SERTRALINE HCL 58 0 31 18
VERAPAMIL ER 57 34 32 95
PREDNISONE 53 26 33 24
LOSARTAN POTASSIUM 53 49 33 17
OXYCODONE HCL-ACETAMINOPHEN 53 17 S2 33 113
ZOSTAVAX 52 47 36 91
METFORMIN HCL 51 42 37 14
GABAPENTIN 50 14 38 12
TRAZODONE HCL 50 0 38 21
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 10, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.